BREF – Biosynex announces a proposed takeover bid for Theradiag at a price of €2.30 per share | Photo credits: Biosynex
Sept 23 (Reuters) – Biosynex says it has filed with the AMF a draft voluntary cash tender offer for Theradiag shares it does not hold. The draft offer is denominated at a price of 2.30 euros per Theradiag share. The price represents a premium of 58.62% over the last quoted price on September 22, 2022 and 43.79% over the average volume-weighted price over the last 60 days preceding the filing of the takeover bid.